{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:08:02Z","timestamp":1791673682463,"version":"4.3.4"},"reference-count":378,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.autrev.2020.102646","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T02:39:01Z","timestamp":1597286341000},"page":"102646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Update on IgG4-mediated autoimmune diseases: New insights and new family members"],"prefix":"10.1016","volume":"19","author":[{"given":"Inga","family":"Koneczny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2020.102646_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00097","article-title":"A new classification system for IgG4 autoantibodies","volume":"9","author":"Koneczny","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0010","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/ene.12758","article-title":"The expanding field of IgG4-mediated neurological autoimmune disorders","volume":"22","author":"Huijbers","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2020.102646_bb0015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2340\/00015555-2611","article-title":"Mortality and cause of death in patients with pemphigus","volume":"97","author":"Kridin","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.autrev.2020.102646_bb0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/jnnp.2006.102517","article-title":"Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in the Netherlands","volume":"78","author":"Niks","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2020.102646_bb0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in myasthenia gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.autrev.2020.102646_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000494291","article-title":"Incidence and prevalence of chronic inflammatory demyelinating Polyradiculoneuropathy: a systematic review and meta-analysis","volume":"52","author":"Broers","year":"2019","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.autrev.2020.102646_bb0035","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000639","article-title":"Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype","volume":"7","author":"Cortese","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflam"},{"key":"10.1016\/j.autrev.2020.102646_bb0040","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jid.2016.07.013","article-title":"Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany","volume":"136","author":"Hubner","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb0045","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus","volume":"394","author":"Schmidt","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2020.102646_bb0050","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jacl.2017.05.017","article-title":"GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia","volume":"11","author":"Hu","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.autrev.2020.102646_bb0055","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1611930","article-title":"Autoantibodies against GPIHBP1 as a cause of hypertriglyceridemia","volume":"376","author":"Beigneux","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102646_bb0060","series-title":"Myasthenia gravis: Pathogenic effects of autoantibodies on neuromuscular architecture, cells 8","author":"Koneczny","year":"2019"},{"key":"10.1016\/j.autrev.2020.102646_bb0065","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s40478-019-0766-7","article-title":"Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity","volume":"7","author":"Duan","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.autrev.2020.102646_bb0070","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3389\/fimmu.2017.00484","article-title":"Eosinophils in autoimmune diseases","volume":"8","author":"Diny","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0075","series-title":"Systemic Lupus Erythematosus","first-page":"321","article-title":"Immune Complexes in Systemic Lupus Erythematosus","author":"Wener","year":"2011"},{"key":"10.1016\/j.autrev.2020.102646_bb0080","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJM197805182982004","article-title":"Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation","volume":"298","author":"Drachman","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102646_bb0085","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1073\/pnas.74.7.3090","article-title":"Modulation of acetylcholine receptor by antibody against the receptor","volume":"74","author":"Heinemann","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102646_bb0090","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12974-016-0689-1","article-title":"Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome","volume":"13","author":"Sabater","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.autrev.2020.102646_bb0095","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonzalez","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2020.102646_bb0100","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2020.102646_bb0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000439002","article-title":"New insights in the pathogenesis of autoimmune hemolytic Anemia","volume":"42","author":"Barcellini","year":"2015","journal-title":"Transfusion Med Hemother"},{"key":"10.1016\/j.autrev.2020.102646_bb0110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","article-title":"Mechanisms of autoantibody-induced pathology","volume":"8","author":"Ludwig","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0115","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"130","author":"Sadler","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2020.102646_bb0120","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1089\/thy.2007.0170","article-title":"The thyrotropin receptor in Graves\u2019 disease","volume":"17","author":"Rapoport","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2020.102646_bb0125","first-page":"673","article-title":"The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies","volume":"19","author":"Rapoport","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.autrev.2020.102646_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080695","article-title":"MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters","volume":"8","author":"Koneczny","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102646_bb0135","doi-asserted-by":"crossref","first-page":"17026","DOI":"10.1038\/nrdp.2017.26","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.autrev.2020.102646_bb0140","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4049\/jimmunol.101.2.317","article-title":"A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody","volume":"101","author":"Lichtenstein","year":"1968","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0145","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4049\/jimmunol.130.2.722","article-title":"Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response","volume":"130","author":"Aalberse","year":"1983","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0150","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000233787","article-title":"The role of IgG4 as blocking antibodies in asthmatics and in bee keepers","volume":"77","author":"Nakagawa","year":"1985","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0155","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(00)04168-4","article-title":"Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study","volume":"357","author":"Platts-Mills","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2020.102646_bb0160","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/216941a0","article-title":"Disulphide bridges of a human immunoglobulin G protein","volume":"216","author":"Pinck","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2020.102646_bb0165","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/216939b0","article-title":"Disulphide bridges of immunoglobin G-1 heavy chains","volume":"216","author":"Frangione","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2020.102646_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/221145a0","article-title":"Structural studies of immunoglobulin G","volume":"221","author":"Frangione","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2020.102646_bb0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1107\/S205225251402209X","article-title":"In-depth analysis of subclass-specific conformational preferences of IgG antibodies","volume":"2","author":"Tian","year":"2015","journal-title":"IUCrJ"},{"key":"10.1016\/j.autrev.2020.102646_bb0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bpc.2017.05.016","article-title":"Antibodies under pressure: a small-angle X-ray scattering study of immunoglobulin G under high hydrostatic pressure","volume":"231","author":"Konig","year":"2017","journal-title":"Biophys Chem"},{"key":"10.1016\/j.autrev.2020.102646_bb0185","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0190","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1529\/biophysj.107.108993","article-title":"Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation","volume":"93","author":"Lu","year":"2007","journal-title":"Biophys J"},{"key":"10.1016\/j.autrev.2020.102646_bb0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1042\/BJ20100641","article-title":"Masking of the fc region in human IgG4 by constrained X-ray scattering modelling: implications for antibody function and therapy","volume":"432","author":"Abe","year":"2010","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2020.102646_bb0200","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.1248943","article-title":"Complement is activated by IgG hexamers assembled at the cell surface","volume":"343","author":"Diebolder","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.autrev.2020.102646_bb0205","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/ndt\/14.4.881","article-title":"Glomerular deposition of mannose-binding lectin in human glomerulonephritis","volume":"14","author":"Lhotta","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2020.102646_bb0210","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s12026-016-8790-1","article-title":"IgG4 anti-phospholipase A2 receptor might activate lectin and alternative complement pathway meanwhile in idiopathic membranous nephropathy: an inspiration from a cross-sectional study","volume":"64","author":"Yang","year":"2016","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2020.102646_bb0215","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00467-009-1439-8","article-title":"IgG subclasses and complement pathway in segmental and global membranous nephropathy","volume":"25","author":"Segawa","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb0220","first-page":"62A","article-title":"Membranous nephropathy-associated anti-phospholipase A2 receptor IgG4 autoantibodies activate the lectin complement pathway (abstract)","volume":"22","author":"Ma","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102646_bb0225","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/ndt\/gfx235","article-title":"Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy","volume":"33","author":"Hayashi","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2020.102646_bb0230","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1172\/JCI72270","article-title":"Membranous nephropathy: from models to man","volume":"124","author":"Beck","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102646_bb0235","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nm0395-237","article-title":"Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein","volume":"1","author":"Malhotra","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2020.102646_bb0240","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.167.5.2861","article-title":"Human IgA activates the complement system via the mannan-binding lectin pathway","volume":"167","author":"Roos","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0245","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.178.2.661","article-title":"Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation","volume":"178","author":"Tao","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102646_bb0250","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1002\/eji.1830241042","article-title":"Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis","volume":"24","author":"Brekke","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0255","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1084\/jem.173.6.1483","article-title":"The binding affinity of human IgG for its high affinity fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region","volume":"173","author":"Canfield","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102646_bb0260","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/35018508","article-title":"The 3.2-a crystal structure of the human IgG1 fc fragment-fc gammaRIII complex","volume":"406","author":"Sondermann","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2020.102646_bb0265","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1074\/jbc.M009483200","article-title":"High resolution mapping of the binding site on human IgG1 for fc gamma RI, fc gamma RII, fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the fc gamma R","volume":"276","author":"Shields","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102646_bb0270","doi-asserted-by":"crossref","first-page":"16469","DOI":"10.1074\/jbc.M100350200","article-title":"The structure of a human type III Fcgamma receptor in complex with fc","volume":"276","author":"Radaev","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102646_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2012.10.029","article-title":"Crystal structure of the human IgG4 C(H)3 dimer reveals the role of Arg409 in the mechanism of fab-arm exchange","volume":"54","author":"Davies","year":"2013","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0280","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.4049\/jimmunol.1003336","article-title":"Species-specific determinants in the IgG CH3 domain enable fab-arm exchange by affecting the noncovalent CH3-CH3 interaction strength","volume":"187","author":"Labrijn","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0285","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.bpj.2019.03.036","article-title":"Structure of a therapeutic full-length anti-NPRA IgG4 antibody: dissecting conformational diversity","volume":"116","author":"Blech","year":"2019","journal-title":"Biophys J"},{"key":"10.1016\/j.autrev.2020.102646_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0161-5890(01)00050-5","article-title":"The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds","volume":"38","author":"Schuurman","year":"2001","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0295","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/pro.5560060217","article-title":"Intrachain disulfide bond in the core hinge region of human IgG4","volume":"6","author":"Bloom","year":"1997","journal-title":"Protein Sci"},{"key":"10.1016\/j.autrev.2020.102646_bb0300","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0161-5890(93)90432-B","article-title":"A single amino acid substitution abolishes the heterogeneity of chimeric mouse\/human (IgG4) antibody","volume":"30","author":"Angal","year":"1993","journal-title":"Mol Immunol"},{"issue":"Pt 2","key":"10.1016\/j.autrev.2020.102646_bb0305","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1042\/bj2810317","article-title":"Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab\u2019 fragment","volume":"281","author":"King","year":"1992","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2020.102646_bb0310","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.iy.06.040188.002535","article-title":"Nonprecipitating asymmetric antibodies","volume":"6","author":"Margni","year":"1988","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0315","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.4049\/jimmunol.137.11.3566","article-title":"Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency","volume":"137","author":"van der Zee","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0320","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1016\/S0021-9258(20)79774-7","article-title":"An in vitro system for studying the kinetics of interchain disulfide bond formation in immunoglobulin G","volume":"249","author":"Petersen","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102646_bb0325","first-page":"1738","article-title":"Characterization and biodistribution of recombinant and recombinant\/chimeric constructs of monoclonal antibody B72.3","volume":"49","author":"Colcher","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2020.102646_bb0330","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.autrev.2020.102646_bb0335","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1074\/jbc.M113.541813","article-title":"Dynamics of inter-heavy chain interactions in human immunoglobulin G (IgG) subclasses studied by kinetic fab arm exchange","volume":"289","author":"Rispens","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102646_bb0340","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/imm.12265","article-title":"Estimation of polyclonal IgG4 hybrids in normal human serum","volume":"142","author":"Young","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2020.102646_bb0345","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2016.11.005","article-title":"IgG4 autoantibodies against muscle-specific kinase undergo fab-arm exchange in myasthenia gravis patients","volume":"77","author":"Koneczny","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102646_bb0350","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","article-title":"Immunoglobulin G4: an odd antibody","volume":"39","author":"Aalberse","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.autrev.2020.102646_bb0355","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/icb.2013.5","article-title":"Enhanced cell-binding by allergen multimers: how complex is it?","volume":"91","author":"Collins","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2020.102646_bb0360","first-page":"415","article-title":"Inhibition of complement activation by IgG4 antibodies","volume":"64","author":"van der Zee","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0365","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jmb.2013.10.039","article-title":"Structural determinants of unique properties of human IgG4-fc","volume":"426","author":"Davies","year":"2014","journal-title":"J Mol Biol"},{"key":"10.1016\/j.autrev.2020.102646_bb0370","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.4049\/jimmunol.0804338","article-title":"Human IgG4 binds to IgG4 and conformationally altered IgG1 via fc-fc interactions","volume":"182","author":"Rispens","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0375","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.4049\/jimmunol.155.10.5057","article-title":"Localization of an fc-binding reactivity to the constant region of human IgG4. Implications for the pathogenesis of rheumatoid arthritis","volume":"155","author":"Zack","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001637","article-title":"A novel immunoglobulin-immunoglobulin interaction in autoimmunity","volume":"3","author":"Kawa","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102646_bb0385","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.4049\/jimmunol.139.5.1466","article-title":"The subclass distribution of human IgG rheumatoid factor","volume":"139","author":"Cohen","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0390","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1365-2559.2010.03717.x","article-title":"Deposition of complement C3c, immunoglobulin (Ig)G4 and IgG at the basement membrane of pancreatic ducts and acini in autoimmune pancreatitis","volume":"57","author":"Detlefsen","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.autrev.2020.102646_bb0395","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.semnephrol.2013.08.004","article-title":"The role of complement in membranous nephropathy","volume":"33","author":"Ma","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb0400","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijpara.2009.10.006","article-title":"Inactivation of the complement anaphylatoxin C5a by secreted products of parasitic nematodes","volume":"40","author":"Rees-Roberts","year":"2010","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.autrev.2020.102646_bb0405","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nri1183","article-title":"Immune regulation by helminth parasites: cellular and molecular mechanisms","volume":"3","author":"Maizels","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0410","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.4049\/jimmunol.176.5.3248","article-title":"Regulatory networks induced by live parasites impair both Th1 and Th2 pathways in patent lymphatic filariasis: implications for parasite persistence","volume":"176","author":"Babu","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0415","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1179\/136485910X12786389891407","article-title":"Induction of immunoglobulin G4 in human filariasis: an indicator of immunoregulation","volume":"104","author":"Adjobimey","year":"2010","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.autrev.2020.102646_bb0420","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1007\/s00436-019-06451-2","article-title":"IgG4 antibodies from patients with asymptomatic bancroftian filariasis inhibit the binding of IgG1 and IgG2 to C1q in a fc-fc-dependent mechanism","volume":"118","author":"Prodjinotho","year":"2019","journal-title":"Parasitol Res"},{"key":"10.1016\/j.autrev.2020.102646_bb0425","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0430","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/BOR.0b013e3283412fd4","article-title":"What is IgG4? A review of the biology of a unique immunoglobulin subtype","volume":"23","author":"Nirula","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102646_bb0435","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0036-1584322","article-title":"The Immunobiology of immunoglobulin G4","volume":"36","author":"Lighaam","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.autrev.2020.102646_bb0440","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2500\/108854187778999667","article-title":"IgG4 and hyposensitization","volume":"8","author":"Van der Zee","year":"1987","journal-title":"N Engl Reg Allergy Proc"},{"key":"10.1016\/j.autrev.2020.102646_bb0445","first-page":"681","article-title":"Immunobiological behaviour of rabbit precipitating and non-precipitating (co-precipitating) antibodies","volume":"41","author":"Margni","year":"1980","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2020.102646_bb0450","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000233000","article-title":"IgG4 and release of histamine from human peripheral blood leukocytes","volume":"67","author":"van Toorenenbergen","year":"1982","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0455","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF02991163","article-title":"IgG4 as a blocking antibody","volume":"1","author":"Aalberse","year":"1983","journal-title":"Clin Rev Allergy"},{"key":"10.1016\/j.autrev.2020.102646_bb0460","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jaci.2012.04.006","article-title":"Allergen specificity of IgG(4)-expressing B cells in patients with grass pollen allergy undergoing immunotherapy","volume":"130","author":"James","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0465","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jaci.2015.01.012","article-title":"IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens","volume":"135","author":"Santos","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0470","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0091-6749(83)90503-1","article-title":"Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens","volume":"72","author":"Kemeny","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0475","first-page":"150","article-title":"Changes in the levels of anti-phospholipase A2 and hyaluronidase antibodies during bee venom immunotherapy","volume":"18","author":"Kemeny","year":"1983","journal-title":"Monogr Allergy"},{"key":"10.1016\/j.autrev.2020.102646_bb0480","doi-asserted-by":"crossref","first-page":"9840890","DOI":"10.1155\/2019\/9840890","article-title":"IgE, IgG1, and IgG4 reactivity to Dermatophagoides pteronyssinus glycosylated extract in allergic patients","volume":"2019","author":"Resende","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.autrev.2020.102646_bb0485","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/all.12236","article-title":"Kinetics, cross-reactivity, and specificity of bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen","volume":"68","author":"Subbarayal","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.autrev.2020.102646_bb0490","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.4049\/jimmunol.163.5.2944","article-title":"Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation","volume":"163","author":"van Neerven","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0495","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000084227","article-title":"Is immunotherapy-induced birch-pollen-specific IgG4 a marker for decreased allergen-specific sensitivity?","volume":"136","author":"Bodtger","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0500","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11882-015-0580-7","article-title":"IgG4 characteristics and functions in Cancer immunity","volume":"16","author":"Crescioli","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.autrev.2020.102646_bb0505","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1097\/MIB.0000000000000889","article-title":"Helminth regulation of immunity: a three-pronged approach to treat colitis","volume":"22","author":"Lopes","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.autrev.2020.102646_bb0510","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/all.13944","article-title":"Regulation of immunity and allergy by helminth parasites","volume":"75","author":"Maizels","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.autrev.2020.102646_bb0515","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1749-6632.2011.06292.x","article-title":"Helminth-host immunological interactions: prevention and control of immune-mediated diseases","volume":"1247","author":"Elliott","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2020.102646_bb0520","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4049\/jimmunol.1601741","article-title":"Cutting edge: helminth coinfection blocks effector differentiation of CD8 T cells through alternate host Th2- and IL-10-mediated responses","volume":"198","author":"Marple","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0525","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2249.1990.tb05492.x","article-title":"IgG subclasses in human chronic schistosomiasis: over-production of schistosome-specific and non-specific IgG4","volume":"82","author":"Boctor","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0530","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1002\/eji.200838193","article-title":"Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR\/GITR-L interaction, IL-10 and TGF-beta","volume":"38","author":"Satoguina","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0535","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00436-019-06247-4","article-title":"Helminths protect against type 1 diabetes: effects and mechanisms","volume":"118","author":"Tang","year":"2019","journal-title":"Parasitol Res"},{"key":"10.1016\/j.autrev.2020.102646_bb0540","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/intimm\/dxv037","article-title":"Suppressive functions of B cells in infectious diseases","volume":"27","author":"Shen","year":"2015","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0545","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2249.2004.02708.x","article-title":"IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin","volume":"139","author":"Chapuy-Regaud","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0550","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3899\/jrheum.130795","article-title":"Immunoglobulin G subclass profile of anticitrullinated peptide antibodies specific for Epstein Barr virus-derived and histone-derived citrullinated peptides","volume":"41","author":"Panza","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102646_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113924","article-title":"IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, fc-glycans and a fab-peptide sequence","volume":"9","author":"Lundstrom","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102646_bb0560","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s10067-018-4053-y","article-title":"Decreased IgG4 ACPA levels in responders and increased CD1c(+) classical dendritic cells in non-responders of patients with rheumatoid arthritis under therapy","volume":"37","author":"Engelmann","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102646_bb0565","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/ard.2008.088401","article-title":"Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis","volume":"68","author":"Bos","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102646_bb0570","first-page":"169","article-title":"Nature, functions, and clinical implications of IgG4 autoantibodies in systemic lupus erythematosus and rheumatoid arthritis","volume":"23","author":"Pan","year":"2017","journal-title":"Discov Med"},{"key":"10.1016\/j.autrev.2020.102646_bb0575","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/art.38335","article-title":"Antibodies to IgG4 hinge can be found in rheumatoid arthritis patients during all stages of disease and may exacerbate chronic antibody-mediated inflammation","volume":"66","author":"van de Stadt","year":"2014","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102646_bb0580","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4049\/jimmunol.1601096","article-title":"Anti-hinge antibodies recognize IgG subclass- and protease-restricted Neoepitopes","volume":"198","author":"Falkenburg","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0585","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/14397595.2018.1558519","article-title":"The front line of research into immunoglobin G4-related disease - do autoantibodies cause immunoglobin G4-related disease?","volume":"29","author":"Umehara","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2020.102646_bb0590","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.it.2018.09.005","article-title":"Mechanistic insights into autoimmune pancreatitis and IgG4-related disease","volume":"39","author":"Watanabe","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0595","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.autrev.2018.09.006","article-title":"Autoimmune pancreatitis in children: the impact of immune system in a challenging disease","volume":"18","author":"Pagliari","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102646_bb0600","doi-asserted-by":"crossref","first-page":"102354","DOI":"10.1016\/j.autrev.2019.102354","article-title":"Characteristics and prognosis of IgG4-related periaortitis\/periarteritis: a systematic literature review","volume":"18","author":"Akiyama","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102646_bb0605","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejim.2019.06.010","article-title":"An update on IgG4-related lung disease","volume":"66","author":"Morales","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2020.102646_bb0610","doi-asserted-by":"crossref","first-page":"102363","DOI":"10.1016\/j.autrev.2019.102363","article-title":"Autoimmune phenomena involving the pituitary gland in children: new developing data about diagnosis and treatment","volume":"18","author":"Romano","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102646_bb0615","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.semdp.2012.08.002","article-title":"IgG4-related disease: nomenclature, clinical features, and treatment","volume":"29","author":"Stone","year":"2012","journal-title":"Semin Diagn Pathol"},{"issue":"11","key":"10.1016\/j.autrev.2020.102646_bb0620","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-211330","article-title":"How to diagnose IgG4-related disease","volume":"76","author":"Umehara","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102646_bb0625","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/BOR.0000000000000383","article-title":"IgG4-related disease","volume":"29","author":"Bozzalla Cassione","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102646_bb0630","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/gutjnl-2015-310336","article-title":"Pathogenicity of IgG in patients with IgG4-related disease","volume":"65","author":"Shiokawa","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2020.102646_bb0635","first-page":"728","article-title":"Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease","volume":"67","author":"Hubers","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2020.102646_bb0640","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaci.2018.05.011","article-title":"Identification of galectin-3 as an autoantigen in patients with IgG4-related disease","volume":"143","author":"Perugino","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198417","article-title":"LatY136F knock-in mouse model for human IgG4-related disease","volume":"13","author":"Yamada","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102646_bb0650","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.1957.02980130015004","article-title":"Chronic thyroiditis and autoimmunization","volume":"164","author":"Witebsky","year":"1957","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2020.102646_bb0655","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0167-5699(93)90244-F","article-title":"Defining criteria for autoimmune diseases(Witebsky\u2019s postulates revisited)","volume":"14","author":"Rose","year":"1993","journal-title":"Immunol Today"},{"key":"10.1016\/j.autrev.2020.102646_bb0660","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.iy.11.040193.000455","article-title":"The role of autoantibodies in autoimmune disease","volume":"11","author":"Naparstek","year":"1993","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0665","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2020.102646_bb0670","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2020.102646_bb0675","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jneuroim.2015.12.016","article-title":"Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity","volume":"291","author":"Huijbers","year":"2016","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0680","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jneuroim.2012.09.001","article-title":"Antibodies against Wnt receptor of muscle-specific tyrosine kinase in myasthenia gravis","volume":"254","author":"Takamori","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0685","doi-asserted-by":"crossref","first-page":"13928","DOI":"10.1038\/srep13928","article-title":"Collagen Q and anti-MuSK autoantibody competitively suppress agrin\/LRP4\/MuSK signaling","volume":"5","author":"Otsuka","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2020.102646_bb0690","doi-asserted-by":"crossref","first-page":"40624","DOI":"10.1074\/jbc.M111.279307","article-title":"Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK)","volume":"286","author":"Zhang","year":"2011","journal-title":"J Biol Chem"},{"issue":"51","key":"10.1016\/j.autrev.2020.102646_bb0695","doi-asserted-by":"crossref","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102646_bb0700","series-title":"Book Potential mechanisms in MuSK myasthenia gravis","article-title":"Potential mechanisms in MuSK myasthenia gravis","author":"Koneczny","year":"2014"},{"key":"10.1016\/j.autrev.2020.102646_bb0705","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1212\/NXI.0000000000000547","article-title":"MuSK myasthenia gravis monoclonal antibodies: Valency dictates pathogenicity","volume":"6","author":"Huijbers","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflam"},{"key":"10.1016\/j.autrev.2020.102646_bb0710","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ajpath.2011.10.031","article-title":"Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis","volume":"180","author":"Mori","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2020.102646_bb0715","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.expneurol.2012.06.034","article-title":"Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors","volume":"237","author":"Morsch","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.autrev.2020.102646_bb0720","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/01.WNL.0000128048.23930.1D","article-title":"Are MuSK antibodies the primary cause of myasthenic symptoms?","volume":"62","author":"Selcen","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2020.102646_bb0725","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.autrev.2020.102646_bb0730","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mus.21642","article-title":"Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia","volume":"42","author":"Niks","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2020.102646_bb0735","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature11348","article-title":"Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses","volume":"489","author":"Yumoto","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2020.102646_bb0740","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuron.2012.04.033","article-title":"Distinct roles of muscle and motoneuron LRP4 in neuromuscular junction formation","volume":"75","author":"Wu","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2020.102646_bb0745","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jns.2019.02.001","article-title":"Cognitive dysfunction in mice with passively induced MuSK antibody seropositive myasthenia gravis","volume":"399","author":"Sabre","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2020.102646_bb0750","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fncel.2013.00196","article-title":"Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases","volume":"7","author":"Faivre-Sarrailh","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.autrev.2020.102646_bb0755","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/emboj\/16.5.978","article-title":"Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions","volume":"16","author":"Peles","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.autrev.2020.102646_bb0760","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.20-22-08354.2000","article-title":"Contactin-associated protein (Caspr) and contactin form a complex that is targeted to the paranodal junctions during myelination","volume":"20","author":"Rios","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2020.102646_bb0765","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0960-9822(01)00680-7","article-title":"Neurofascin is a glial receptor for the paranodin\/Caspr-contactin axonal complex at the axoglial junction","volume":"12","author":"Charles","year":"2002","journal-title":"Curr Biol"},{"key":"10.1016\/j.autrev.2020.102646_bb0770","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1093\/brain\/aww189","article-title":"Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy","volume":"139","author":"Doppler","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2020.102646_bb0775","first-page":"370","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"3","author":"Querol","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2020.102646_bb0780","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/brain\/awv054","article-title":"Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia","volume":"138","author":"Miura","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2020.102646_bb0785","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp-2014-309916","article-title":"Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies","volume":"86","author":"Doppler","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2020.102646_bb0790","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1074\/jbc.M113.528489","article-title":"Specific contactin N-glycans are implicated in neurofascin binding and autoimmune targeting in peripheral neuropathies","volume":"289","author":"Labasque","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102646_bb0795","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ki.2012.321","article-title":"Neuronal proteins are novel components of podocyte major processes and their expression in glomerular crescents supports their role in crescent formation","volume":"83","author":"Sistani","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2020.102646_bb0800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-328X(94)90372-7","article-title":"Identification and characterization of the human cell adhesion molecule contactin","volume":"21","author":"Reid","year":"1994","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.autrev.2020.102646_bb0805","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1002\/mus.26392","article-title":"\u201cneuro-renal syndrome\u201d related to anti-contactin-1 antibodies","volume":"59","author":"Taieb","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2020.102646_bb0810","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12974-019-1462-z","article-title":"Anti-CNTN1 IgG3 induces acute conduction block and motor deficits in a passive transfer rat model","volume":"16","author":"Doppler","year":"2019","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.autrev.2020.102646_bb0815","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"Kanigicherla","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2020.102646_bb0820","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/brain\/aww062","article-title":"Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects","volume":"139","author":"Manso","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2020.102646_bb0825","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0896-6273(01)00294-X","article-title":"Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV\/Caspr\/Paranodin","volume":"30","author":"Bhat","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2020.102646_bb0830","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0896-6273(01)00296-3","article-title":"Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve","volume":"30","author":"Boyle","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2020.102646_bb0835","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neuron.2005.10.019","article-title":"Neurofascins are required to establish axonal domains for saltatory conduction","volume":"48","author":"Sherman","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2020.102646_bb0840","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","article-title":"Neurofascin as a target for autoantibodies in peripheral neuropathies","volume":"79","author":"Ng","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2020.102646_bb0845","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2020.102646_bb0850","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2016.10.013","article-title":"IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: clinical significance and diagnostic utility of a conventional assay","volume":"301","author":"Kadoya","year":"2016","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0855","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/acn3.539","article-title":"Head and voice tremor improving with immunotherapy in an anti-NF155 positive CIDP patient","volume":"5","author":"Painous","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.autrev.2020.102646_bb0860","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000149","article-title":"Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins","volume":"2","author":"Querol","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2020.102646_bb0865","doi-asserted-by":"crossref","first-page":"606","DOI":"10.5334\/tohm.451","article-title":"Tremor associated with chronic inflammatory demyelinating polyneuropathy and anti-Neurofascin-155 antibodies","volume":"8","author":"Bailly","year":"2018","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"10.1016\/j.autrev.2020.102646_bb0870","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jneuroim.2019.01.017","article-title":"Tongue tremor in neurofascin-155 IgG4 seropositive chronic inflammatory polyradiculoneuropathy","volume":"330","author":"Briani","year":"2019","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0875","article-title":"Anti-Neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo","volume":"130","author":"Manso","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102646_bb0880","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.1073\/pnas.1811013115","article-title":"Regulation of myelin structure and conduction velocity by perinodal astrocytes","volume":"115","author":"Dutta","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102646_bb0885","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ebiom.2015.06.007","article-title":"Pathogenicity of anti-ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic Purpura","volume":"2","author":"Thomas","year":"2015","journal-title":"Ebiomedicine"},{"key":"10.1016\/j.autrev.2020.102646_bb0890","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102646_bb0895","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1182\/blood-2014-04-561142","article-title":"The splenic autoimmune response to ADAMTS13 in thrombotic thrombocytopenic purpura contains recurrent antigen-binding CDR3 motifs","volume":"124","author":"Schaller","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2020.102646_bb0900","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3389\/fimmu.2018.01646","article-title":"Concentration and subclass distribution of anti-ADAMTS13 IgG autoantibodies in different stages of acquired idiopathic thrombotic thrombocytopenic Purpura","volume":"9","author":"Sinkovits","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0905","doi-asserted-by":"crossref","first-page":"17020","DOI":"10.1038\/nrdp.2017.20","article-title":"Thrombotic thrombocytopenic purpura","volume":"3","author":"Kremer Hovinga","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.autrev.2020.102646_bb0910","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/trf.13583","article-title":"ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 2. Pathogenicity in an animal model","volume":"56","author":"Ostertag","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.autrev.2020.102646_bb0915","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMra061111","article-title":"Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome","volume":"355","author":"Stanley","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102646_bb0920","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1067\/mjd.2003.7","article-title":"Desmoglein as a target in autoimmunity and infection","volume":"48","author":"Amagai","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb0925","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1172\/JCI64413","article-title":"Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface","volume":"122","author":"Di Zenzo","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102646_bb0930","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1084\/jem.20022031","article-title":"The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem)","volume":"197","author":"Li","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102646_bb0935","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0923-1811(00)00158-4","article-title":"Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus","volume":"26","author":"Futei","year":"2001","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2020.102646_bb0940","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJM198906013202206","article-title":"The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem)","volume":"320","author":"Rock","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102646_bb0945","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1172\/JCI24185","article-title":"Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display","volume":"115","author":"Payne","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102646_bb0950","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.0022-202X.2005.23714.x","article-title":"In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris","volume":"124","author":"Ishii","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb0955","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050696","article-title":"Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation","volume":"7","author":"Saito","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102646_bb0960","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaut.2017.12.017","article-title":"Pathogenic IgG4 autoantibodies from endemic pemphigus foliaceus recognize a desmoglein-1 conformational epitope","volume":"89","author":"Evangelista","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102646_bb0965","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1083\/jcb.200605125","article-title":"Inhibition of rho a activity causes pemphigus skin blistering","volume":"175","author":"Waschke","year":"2006","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2020.102646_bb0970","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4049\/jimmunol.182.1.711","article-title":"Involvement of the apoptotic mechanism in pemphigus foliaceus autoimmune injury of the skin","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0975","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3389\/fimmu.2017.01022","article-title":"Crosstalk between signaling pathways in pemphigus: a role for endoplasmic reticulum stress in p38 mitogen-activated protein kinase activation?","volume":"8","author":"Cipolla","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0980","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/bjd.15721","article-title":"Inhibition of p38MAPK signaling prevents epidermal blistering and alterations of desmosome structure induced by pemphigus autoantibodies in human epidermis","volume":"6","author":"Egu","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb0985","first-page":"728529","article-title":"p38 MAPK signaling in pemphigus: implications for skin autoimmunity","volume":"2013","author":"Mavropoulos","year":"2013","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.autrev.2020.102646_bb0990","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.4049\/jimmunol.1002675","article-title":"Protective endogenous cyclic adenosine 5\u2032-monophosphate signaling triggered by pemphigus autoantibodies","volume":"185","author":"Spindler","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb0995","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1038\/s41598-017-03697-7","article-title":"Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus","volume":"7","author":"Walter","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2020.102646_bb1000","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-2133.2012.11144.x","article-title":"Enrichment of total serum IgG4 in patients with pemphigus","volume":"167","author":"Funakoshi","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/pde.12859","article-title":"Neonatal autoimmune blistering disease: a systematic review","volume":"33","author":"Zhao","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1010","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.4049\/jimmunol.170.4.2170","article-title":"Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3","volume":"170","author":"Tsunoda","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb1015","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2020.102646_bb1020","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2020.102646_bb1025","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1-associated cognitive impairment: presentation and long-term outcome","volume":"87","author":"Arino","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2020.102646_bb1030","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2020.102646_bb1035","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/WCO.0000000000000444","article-title":"Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies)","volume":"30","author":"Bastiaansen","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2020.102646_bb1040","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1126\/science.1129947","article-title":"Epilepsy-related ligand\/receptor complex LGI1 and ADAM22 regulate synaptic transmission","volume":"313","author":"Fukata","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.autrev.2020.102646_bb1045","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/s41467-018-03947-w","article-title":"Structural basis of epilepsy-related ligand-receptor complex LGI1-ADAM22","volume":"9","author":"Yamagata","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2020.102646_bb1050","doi-asserted-by":"crossref","first-page":"E4129","DOI":"10.1073\/pnas.1511910112","article-title":"The LGI1-ADAM22 protein complex directs synapse maturation through regulation of PSD-95 function","volume":"112","author":"Lovero","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102646_bb1055","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/brain\/awx070","article-title":"Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis","volume":"140","author":"Miller","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2020.102646_bb1060","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/WNR.0000000000001055","article-title":"Effect of LGI1 antibody-positive IgG on hippocampal neuron survival: a preliminary study","volume":"29","author":"Aysit-Altuncu","year":"2018","journal-title":"Neuroreport"},{"key":"10.1016\/j.autrev.2020.102646_bb1065","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","article-title":"Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors","volume":"33","author":"Ohkawa","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2020.102646_bb1070","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/brain\/awx323","article-title":"The importance of early immunotherapy in patients with faciobrachial dystonic seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2020.102646_bb1075","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1073\/pnas.1618656114","article-title":"LGI1 tunes intrinsic excitability by regulating the density of axonal Kv1 channels","volume":"114","author":"Seagar","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102646_bb1080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2019.04.012","article-title":"ADAM23 is a negative regulator of Kv1.1\/Kv1.4 potassium currents","volume":"704","author":"Lancaster","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.autrev.2020.102646_bb1085","first-page":"3144","article-title":"LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory","volume":"141","author":"Petit-Pedrol","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2020.102646_bb1090","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1528-1167.2010.02756.x","article-title":"Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission","volume":"52","author":"Lalic","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.autrev.2020.102646_bb1095","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/hmg\/ddq047","article-title":"Lgi1 null mutant mice exhibit myoclonic seizures and CA1 neuronal hyperexcitability","volume":"19","author":"Yu","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2020.102646_bb1100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2020.102646_bb1105","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1097\/JTO.0b013e3181f23f04","article-title":"Caspr2 antibodies in patients with thymomas","volume":"5","author":"Vincent","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.autrev.2020.102646_bb1110","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(16)31459-3","article-title":"Morvan syndrome as a paraneoplastic disorder of thymoma with anti-CASPR2 antibodies","volume":"389","author":"Vale","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2020.102646_bb1115","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis","volume":"13","author":"van Sonderen","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2020.102646_bb1120","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2020.102646_bb1125","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jamaneurol.2016.1585","article-title":"Characterization of a subtype of autoimmune encephalitis with anti-Contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures","volume":"73","author":"Joubert","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.autrev.2020.102646_bb1130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2015.03.005","article-title":"Clinical manifestations of patients with CASPR2 antibodies","volume":"281","author":"Sunwoo","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102646_bb1135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamaneurol.2013.592","article-title":"Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping","volume":"70","author":"Klein","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2020.102646_bb1140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ene.13180","article-title":"Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome","volume":"24","author":"Bien","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2020.102646_bb1145","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1176\/jnp.23.4.jnp425","article-title":"Psychiatric manifestations of voltage-gated potassium-channel complex autoimmunity","volume":"23","author":"Somers","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.autrev.2020.102646_bb1150","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0896-6273(00)81049-1","article-title":"Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels","volume":"24","author":"Poliak","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2020.102646_bb1155","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/cercor\/bhx341","article-title":"Loss of Cntnap2 causes axonal excitability deficits, developmental delay in cortical myelination, and abnormal stereotyped motor behavior","volume":"29","author":"Scott","year":"2019","journal-title":"Cerebral Cortex"},{"key":"10.1016\/j.autrev.2020.102646_bb1160","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.neuron.2018.01.033","article-title":"Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability","volume":"97","author":"Dawes","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2020.102646_bb1165","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ana.25120","article-title":"Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia","volume":"83","author":"Patterson","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2020.102646_bb1170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fncel.2015.00265","article-title":"Inhibitory axons are targeted in hippocampal cell culture by anti-Caspr2 autoantibodies associated with limbic encephalitis","volume":"9","author":"Pinatel","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.autrev.2020.102646_bb1175","doi-asserted-by":"crossref","first-page":"102284","DOI":"10.1016\/j.jaut.2019.05.012","article-title":"Impact of anti-CASPR2 autoantibodies from patients with autoimmune encephalitis on CASPR2\/TAG-1 interaction and Kv1 expression","volume":"103","author":"Saint-Martin","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102646_bb1180","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1093\/cercor\/bhz032","article-title":"Disrupted AMPA receptor function upon genetic- or antibody-mediated loss of autism-associated CASPR2","volume":"12","author":"Fernandes","year":"2019","journal-title":"Cereb Cortex"},{"issue":"7","key":"10.1016\/j.autrev.2020.102646_bb1185","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/brain\/awz119","article-title":"Behaviour and neuropathology in mice injected with human contactin-associated protein 2 antibodies","volume":"142","author":"Giannoccaro","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2020.102646_bb1190","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/jnnp-2011-301506","article-title":"Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia","volume":"83","author":"Becker","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2020.102646_bb1195","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cmet.2010.04.016","article-title":"GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries","volume":"12","author":"Davies","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2020.102646_bb1200","article-title":"The acidic domain of the endothelial membrane protein GPIHBP1 stabilizes lipoprotein lipase activity by preventing unfolding of its catalytic domain","volume":"5","author":"Mysling","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.autrev.2020.102646_bb1205","article-title":"The angiopoietin-like protein ANGPTL4 catalyzes unfolding of the hydrolase domain in lipoprotein lipase and the endothelial membrane protein GPIHBP1 counteracts this unfolding","volume":"5","author":"Mysling","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.autrev.2020.102646_bb1210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jacl.2018.10.004","article-title":"GPIHBP1 autoantibody syndrome during interferon beta1a treatment","volume":"13","author":"Eguchi","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.autrev.2020.102646_bb1215","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/postgradmedj-2018-135729","article-title":"Primary membranous nephropathy: comprehensive review and historical perspective","volume":"95","author":"Keri","year":"2019","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.autrev.2020.102646_bb1220","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.kint.2016.09.048","article-title":"Membranous nephropathy: integrating basic science into improved clinical management","volume":"91","author":"Cattran","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2020.102646_bb1225","first-page":"57","article-title":"Distribution of IgG subclasses in membranous nephropathy","volume":"58","author":"Doi","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb1230","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1681\/ASN.2016070776","article-title":"A proposal for a serology-based approach to membranous nephropathy","volume":"28","author":"De Vriese","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1235","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102646_bb1240","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2018.12.027","article-title":"Serum phospholipase A2 receptor antibodies and immunoglobulin G subtypes in adult idiopathic membranous nephropathy: clinical value assessment","volume":"490","author":"Cheng","year":"2019","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2020.102646_bb1245","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2215\/CJN.02170312","article-title":"Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy","volume":"7","author":"Murtas","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1250","article-title":"A comparison of clinical features between idiopathic membranous nephropathy patients with and without serum antibody against phospholipase A2 receptor","volume":"98","author":"Zhang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2020.102646_bb1255","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2012030242","article-title":"Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy","volume":"23","author":"Hofstra","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1260","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/0961203319828521","article-title":"Antibodies to M-type phospholipase A2 receptor (PLA2R) in membranous lupus nephritis","volume":"28","author":"Garcia-Vives","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102646_bb1265","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ekir.2017.08.005","article-title":"Concurrent presentation of thrombotic thrombocytopenic Purpura and membranous nephropathy","volume":"3","author":"Al-Rabadi","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.autrev.2020.102646_bb1270","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/modpathol.2012.237","article-title":"IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression","volume":"26","author":"Huang","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.autrev.2020.102646_bb1275","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MNH.0000000000000459","article-title":"Unmet challenges in membranous nephropathy","volume":"28","author":"Salant","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.autrev.2020.102646_bb1280","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0165-6147(99)01300-0","article-title":"Receptors for a growing family of secreted phospholipases A2","volume":"20","author":"Lambeau","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.autrev.2020.102646_bb1285","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.semcancer.2017.11.002","article-title":"Current insights into functions of phospholipase A2 receptor in normal and cancer cells: more questions than answers","volume":"56","author":"Sukocheva","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.autrev.2020.102646_bb1290","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1038\/s41598-017-07028-8","article-title":"PLA2R binds to the annexin A2-S100A10 complex in human podocytes","volume":"7","author":"Fresquet","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2020.102646_bb1295","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.3390\/ijms14036259","article-title":"Annexin A2 heterotetramer: structure and function","volume":"14","author":"Bharadwaj","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2020.102646_bb1300","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2014050502","article-title":"Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy","volume":"26","author":"Fresquet","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1305","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1681\/ASN.2013121315","article-title":"Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy","volume":"26","author":"Kao","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1310","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/eci.12292","article-title":"Serum with phospholipase A2 receptor autoantibodies interferes with podocyte adhesion to collagen","volume":"44","author":"Skoberne","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102646_bb1315","doi-asserted-by":"crossref","first-page":"7935","DOI":"10.1074\/jbc.M113.512780","article-title":"Complex determinants in specific members of the mannose receptor family govern collagen endocytosis","volume":"289","author":"Jurgensen","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102646_bb1320","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1681\/ASN.2017020178","article-title":"PLA2R and THSD7A: disparate paths to the same disease?","volume":"28","author":"Beck","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1325","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jfma.2018.12.026","article-title":"The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy","volume":"118","author":"Chi","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.autrev.2020.102646_bb1330","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cca.2018.06.050","article-title":"Clinical and prognostic significance of glomerular C1q deposits in primary MN","volume":"485","author":"Zhang","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2020.102646_bb1335","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10157-014-1064-0","article-title":"Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese","volume":"19","author":"Hayashi","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1340","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1681\/ASN.2012060577","article-title":"Recurrent membranous nephropathy in an allograft caused by IgG3kappa targeting the PLA2 receptor","volume":"23","author":"Debiec","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1345","first-page":"109A","article-title":"An in vitro model of idiopathic membranous nephropathy reveals PLA2R- and complement-dependent pathways of podocyte injury","volume":"20","author":"Haddad","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1350","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/ndt\/gfx235","article-title":"Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy","volume":"33","author":"Hayashi","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2020.102646_bb1355","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1681\/ASN.2015101155","article-title":"Phospholipase A2 receptor-related membranous nephropathy and Mannan-binding lectin deficiency","volume":"27","author":"Bally","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1360","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.imbio.2015.01.003","article-title":"Primary Ficolin-3 deficiency--is it associated with increased susceptibility to infections?","volume":"220","author":"Michalski","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.autrev.2020.102646_bb1365","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fimmu.2018.00553","article-title":"Novel concepts of altered immunoglobulin G Galactosylation in autoimmune diseases","volume":"9","author":"Dekkers","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb1370","doi-asserted-by":"crossref","first-page":"F487","DOI":"10.1152\/ajprenal.00275.2016","article-title":"Optimizing the translational value of animal models of glomerulonephritis: insights from recent murine prototypes","volume":"311","author":"Foster","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.autrev.2020.102646_bb1375","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3389\/fimmu.2018.01433","article-title":"Alternative pathway is essential for glomerular complement activation and proteinuria in a mouse model of membranous nephropathy","volume":"9","author":"Luo","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb1380","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2016010050","article-title":"An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy","volume":"28","author":"Hoxha","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1385","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/prot.25640","article-title":"Structure and function insights garnered from in silico modeling of the thrombospondin type-1 domain-containing 7A antigen","volume":"87","author":"Stoddard","year":"2019","journal-title":"Proteins"},{"key":"10.1016\/j.autrev.2020.102646_bb1390","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1681\/ASN.2017070805","article-title":"The most N-terminal region of THSD7A is the predominant target for autoimmunity in THSD7A-associated membranous nephropathy","volume":"29","author":"Seifert","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1395","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1681\/ASN.2018090941","article-title":"Thrombospondin type 1 domain-containing 7A localizes to the slit diaphragm and stabilizes membrane dynamics of fully differentiated podocytes","volume":"30","author":"Herwig","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138841","article-title":"Prevalence of enhanced granular expression of thrombospondin Type-1 domain-containing 7A in the glomeruli of Japanese patients with idiopathic membranous nephropathy","volume":"10","author":"Iwakura","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102646_bb1405","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102646_bb1410","doi-asserted-by":"crossref","first-page":"1936372","DOI":"10.1155\/2017\/1936372","article-title":"Recent Progress in deciphering the Etiopathogenesis of primary membranous nephropathy","volume":"2017","author":"Kronbichler","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.autrev.2020.102646_bb1415","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.2215\/CJN.01460217","article-title":"Circulating antibodies against thrombospondin type-I domain-containing 7A in Chinese patients with idiopathic membranous nephropathy","volume":"12","author":"Wang","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1420","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMc1511702","article-title":"A mechanism for Cancer-associated membranous nephropathy","volume":"374","author":"Hoxha","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102646_bb1425","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1172\/JCI85265","article-title":"Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy","volume":"126","author":"Tomas","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102646_bb1430","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1681\/ASN.2017010030","article-title":"A heterologous model of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy","volume":"11","author":"Tomas","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1435","article-title":"Human anti-thrombospondin type 1 domain-containing 7A antibodies induce membranous nephropathy through activation of lectin complement pathway","volume":"38","author":"Wang","year":"2018","journal-title":"Biosci Rep"},{"key":"10.1016\/j.autrev.2020.102646_bb1440","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/bjd.17202","article-title":"A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid","volume":"180","author":"Goletz","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1445","first-page":"85","article-title":"Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa","volume":"64","author":"Verrando","year":"1991","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2020.102646_bb1450","first-page":"373","article-title":"Keratinocyte footprint assay discriminates antilaminin-332 pemphigoid from all other forms of pemphigoid diseases","volume":"2","author":"Giurdanella","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1455","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/1523-1747.ep12292578","article-title":"Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid","volume":"108","author":"Chan","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1460","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1172\/JCI116033","article-title":"Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease","volume":"90","author":"Domloge-Hultsch","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102646_bb1465","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaad.2008.02.035","article-title":"IgG anti-laminin-332 autoantibodies are present in a subset of patients with mucous membrane, but not bullous, pemphigoid","volume":"58","author":"Lazarova","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1470","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/S0140-6736(00)04971-0","article-title":"Anti-epiligrin cicatricial pemphigoid and relative risk for cancer","volume":"357","author":"Egan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2020.102646_bb1475","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1346-8138.2004.tb00497.x","article-title":"A case of anti-epiligrin cicatricial pemphigoid associated with lung carcinoma and severe laryngeal stenosis: review of Japanese cases and evaluation of risk for internal malignancy","volume":"31","author":"Matsushima","year":"2004","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1480","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archderm.135.9.1091","article-title":"Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases?","volume":"135","author":"Leverkus","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1485","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2133.2011.10474.x","article-title":"Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin-332 mucous membrane pemphigoid: immunopathological findings and clinical experience in 10 Dutch patients","volume":"165","author":"Terra","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1490","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5826\/dpc.0902a07","article-title":"Mucous membrane pemphigoid-associated malignancies: case series and a brief overview of the literature","volume":"9","author":"La Placa","year":"2019","journal-title":"Dermatol Pract Concept"},{"key":"10.1016\/j.autrev.2020.102646_bb1495","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0092-8674(91)90092-D","article-title":"Epiligrin, a new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membranes","volume":"65","author":"Carter","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2020.102646_bb1500","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1083\/jcb.114.3.567","article-title":"Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments","volume":"114","author":"Rousselle","year":"1991","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2020.102646_bb1505","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/1346-8138.15083","article-title":"Detachment of keratinocytes at the basement membrane zone caused by inhibitory effect of the antibodies from sera of mucous membrane pemphigoid patients","volume":"46","author":"Koga","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1510","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.1523-1747.2000.00829.x","article-title":"Human anti-laminin 5 autoantibodies induce subepidermal blisters in an experimental human skin graft model","volume":"114","author":"Lazarova","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1515","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/brain\/awx124","article-title":"Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy","volume":"140","author":"Delmont","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2020.102646_bb1520","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ensci.2018.11.016","article-title":"Presence of both anti-contactin 1 and anti-neurofascin 140 antibodies in a case of chronic inflammatory demyelinating polyneuropathy","volume":"13","author":"Lin","year":"2018","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.autrev.2020.102646_bb1525","series-title":"Anti-glomerular basement membrane disease: An update on subgroups, pathogenesis and therapies, Nephrol dial transplant","author":"Segelmark","year":"2018"},{"key":"10.1016\/j.autrev.2020.102646_bb1530","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12882-018-1197-6","article-title":"Recurrence of Goodpasture syndrome without circulating anti-glomerular basement membrane antibodies after kidney transplant, a case report","volume":"20","author":"Thibaud","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1535","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1084\/jem.126.6.989","article-title":"The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis","volume":"126","author":"Lerner","year":"1967","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102646_bb1540","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.ajkd.2013.08.032","article-title":"Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease","volume":"63","author":"Ohlsson","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2020.102646_bb1545","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/ndt\/gfl841","article-title":"Linear anti-glomerular basement membrane IgG but no glomerular disease: Goodpasture\u2019s syndrome restricted to the lung","volume":"22","author":"Sethi","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2020.102646_bb1550","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/sj.ki.5002525","article-title":"Antiglomerular basement membrane disease with normal renal function","volume":"72","author":"Cui","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2020.102646_bb1555","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2172-14-19","article-title":"The distribution of IgG subclass deposition on renal tissues from patients with anti-glomerular basement membrane disease","volume":"14","author":"Qu","year":"2013","journal-title":"BMC Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb1560","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jprot.2011.05.021","article-title":"Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: alfa-enolase and borderline antigens","volume":"74","author":"Bruschi","year":"2011","journal-title":"J Proteomics"},{"key":"10.1016\/j.autrev.2020.102646_bb1565","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2008121259","article-title":"Autoimmunity in membranous nephropathy targets aldose reductase and SOD2","volume":"21","author":"Prunotto","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1570","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/bi00220a034","article-title":"Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor","volume":"30","author":"Miles","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.autrev.2020.102646_bb1575","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10157-016-1235-2","article-title":"Circulating antibodies to alpha-enolase and phospholipase A2 receptor and composition of glomerular deposits in Japanese patients with primary or secondary membranous nephropathy","volume":"21","author":"Kimura","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1580","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1196\/annals.1405.040","article-title":"Myasthenia gravis in the elderly: is it different?","volume":"1132","author":"Aarli","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2020.102646_bb1585","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/1523-1747.ep12349283","article-title":"A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone","volume":"106","author":"Zillikens","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1590","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2133.1996.tb07625.x","article-title":"Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen","volume":"134","author":"Chen","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1595","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3389\/fimmu.2019.02466","article-title":"Anti-p200 pemphigoid: a systematic review","volume":"10","author":"Kridin","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb1600","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/ijd.13616","article-title":"Chronic bullous disease of childhood with IgG reactivity to p200 antigen","volume":"56","author":"Patsatsi","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1605","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/1523-1747.ep12343631","article-title":"A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone","volume":"106","author":"Zillikens","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1610","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1523-1747.2003.12609.x","article-title":"The autoantigen of anti-p200 pemphigoid is an acidic noncollagenous N-linked glycoprotein of the cutaneous basement membrane","volume":"121","author":"Shimanovich","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1615","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jamadermatol.2018.5536","article-title":"Overlap of bullous, anti-Laminin-332, and anti-p200 pemphigoid with concomitant anti-Contactin-1-positive inflammatory polyneuropathy treated with intravenous immunoglobulins as a manifestation of epitope spreading","volume":"155","author":"Wald","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1620","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1346-8138.2009.00793.x","article-title":"From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid","volume":"37","author":"Dainichi","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1625","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1073\/pnas.0809230106","article-title":"Anti-laminin gamma-1 pemphigoid","volume":"106","author":"Dainichi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102646_bb1630","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2133.2010.10056.x","article-title":"Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid","volume":"164","author":"Groth","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1635","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1365-2133.2012.11076.x","article-title":"A long-term study of a patient with anti-p200 pemphigoid: correlation of autoantibody levels with disease activity and an example of epitope spreading","volume":"167","author":"Monshi","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1640","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041769","article-title":"Pathogenicity of autoantibodies in anti-p200 pemphigoid","volume":"7","author":"Vafia","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102646_bb1645","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jdermsci.2013.01.001","article-title":"An attempt to develop mouse model for anti-laminin gamma1 pemphigoid","volume":"70","author":"Koga","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2020.102646_bb1650","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3389\/fimmu.2018.00680","article-title":"Pathogenetic and clinical aspects of anti-neutrophil cytoplasmic autoantibody-associated Vasculitides","volume":"9","author":"Lamprecht","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb1655","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2249.2004.02566.x","article-title":"Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener\u2019s granulomatosis: a possible pathogenic role for the IgG4 subclass","volume":"138","author":"Holland","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb1660","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2249.1991.tb05647.x","article-title":"Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener\u2019s granulomatosis and clinically related disorders","volume":"83","author":"Brouwer","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb1665","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2567.2009.03108.x","article-title":"Chimeric IgG4 PR3-ANCA induces selective inflammatory responses from neutrophils through engagement of Fcgamma receptors","volume":"128","author":"Hussain","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2020.102646_bb1670","doi-asserted-by":"crossref","first-page":"121702","DOI":"10.1155\/2012\/121702","article-title":"Increased IgG4-positive plasma cells in granulomatosis with Polyangiitis: a diagnostic pitfall of IgG4-related disease","volume":"2012","author":"Chang","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1675","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s11102-015-0650-9","article-title":"A diagnostic pitfall in IgG4-related hypophysitis: infiltration of IgG4-positive cells in the pituitary of granulomatosis with polyangiitis","volume":"18","author":"Bando","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.autrev.2020.102646_bb1680","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/1756-185X.12687","article-title":"Medical mirroring: granulomatosis with polyangiitis (formerly Wegener's) mimicking immunoglobulin-G4 related disease","volume":"21","author":"Kaushik","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102646_bb1685","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004633","article-title":"Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: a case report and review of the literature","volume":"95","author":"Della-Torre","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2020.102646_bb1690","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-226280","article-title":"Granulomatosis with polyangiitis in a patient with biopsy-proven IgG4-related pulmonary disease and coincident small cell lung cancer","volume":"12","author":"Abbass","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.autrev.2020.102646_bb1695","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1212\/NXI.0000000000000341","article-title":"IgG4-related hypertrophic pachymeningitis coexpressing antineutrophil cytoplasmic antibodies","volume":"4","author":"Massey","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflam"},{"issue":"Suppl. 111","key":"10.1016\/j.autrev.2020.102646_bb1700","first-page":"172","article-title":"Rapidly progressive glomerulonephritis caused by overlap syndrome of IgG4-related tubulointerstitial nephritis and myeloperoxidase-antineutrophil cytoplasmic antibody-associated necrotising glomerulonephritis","volume":"36","author":"Watanabe","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1705","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006707","article-title":"Concurrent IgG4-related tubulointerstitial nephritis and IgG4 myeloperoxidase-anti-neutrophil cytoplasmic antibody positive crescentic glomerulonephritis: a case report","volume":"96","author":"Su","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2020.102646_bb1710","first-page":"92","article-title":"A case of proteinase 3 anti-neutrophil cytoplasmic antibody (PR3-ANCA) positive\/IgG4-related lung disease","volume":"20","author":"Touge","year":"2017","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.autrev.2020.102646_bb1715","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.autrev.2017.07.020","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome","volume":"16","author":"Danlos","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102646_bb1720","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11926-013-0348-9","article-title":"IgG4-associated vasculitis","volume":"15","author":"Perez Alamino","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2020.102646_bb1725","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12026-019-9070-7","article-title":"Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature","volume":"67","author":"Kawashima","year":"2019","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2020.102646_bb1730","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.autrev.2017.07.020","article-title":"Comment on the article entitled \u201cAntineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome\u201d","volume":"16","author":"Goulabchand","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102646_bb1735","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10067-018-4402-x","article-title":"No overlap between IgG4-related disease and microscopic polyangiitis and granulomatosis with polyangiitis despite elevated serum IgG4 at diagnosis: a retrospective monocentric study","volume":"38","author":"Yoo","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1740","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13075-018-1806-6","article-title":"IgG4:IgG RNA ratio differentiates active disease from remission in granulomatosis with polyangiitis: a new disease activity marker? A cross-sectional and longitudinal study","volume":"21","author":"Al-Soudi","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2020.102646_bb1745","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12882-018-0922-5","article-title":"Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A2 receptor in membranous nephropathy-lesions: report of two patients with microscopic polyangiitis","volume":"19","author":"Tominaga","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.autrev.2020.102646_bb1750","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001472","article-title":"Clinical and immunologic characteristics of patients with ANCA-associated glomerulonephritis combined with membranous nephropathy: a retrospective cohort study in a single Chinese center","volume":"94","author":"Zou","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2020.102646_bb1755","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjd.17923","article-title":"Concurrent mucous membrane pemphigoid and membranous glomerulonephritis in a patient with autoantibodies targeting the 1080 region of collagen XVII","volume":"4","author":"Stump","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1760","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/jdv.15325","article-title":"Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid","volume":"33","author":"Zheng","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2020.102646_bb1765","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1172\/JCI114812","article-title":"Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome","volume":"86","author":"Diaz","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102646_bb1770","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0092-8674(81)90115-X","article-title":"Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia","volume":"24","author":"Stanley","year":"1981","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2020.102646_bb1775","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-007-0734-0","article-title":"The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases","volume":"299","author":"Sitaru","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2020.102646_bb1780","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/1346-8138.13051","article-title":"Serum levels of immunoglobulins G1 and G4 targeting the non-collagenous 16A domain of BP180 reflect bullous pemphigoid activity and predict bad prognosis","volume":"43","author":"Zhou","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1785","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1172\/JCI117826","article-title":"The role of complement in experimental bullous pemphigoid","volume":"95","author":"Liu","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102646_bb1790","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1172\/JCI11494","article-title":"Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid","volume":"108","author":"Chen","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102646_bb1795","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1172\/JCI3693","article-title":"A critical role for neutrophil elastase in experimental bullous pemphigoid","volume":"105","author":"Liu","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102646_bb1800","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ajpath.2012.11.029","article-title":"Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway","volume":"182","author":"Hiroyasu","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2020.102646_bb1805","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/jid.2008.305","article-title":"IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment","volume":"129","author":"Iwata","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2020.102646_bb1810","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.4049\/jimmunol.1400095","article-title":"Bullous pemphigoid autoantibodies directly induce blister formation without complement activation","volume":"193","author":"Ujiie","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb1815","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaut.2016.06.019","article-title":"IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid","volume":"73","author":"Zuo","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102646_bb1820","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.23756","article-title":"Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels","volume":"73","author":"Boronat","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2020.102646_bb1825","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/WNL.0000000000003796","article-title":"DPPX antibody-associated encephalitis: Main syndrome and antibody effects","volume":"88","author":"Hara","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2020.102646_bb1830","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000001907","article-title":"Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons","volume":"85","author":"Piepgras","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2020.102646_bb1835","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13292","article-title":"High prevalence and functional effects of serum antineuronal antibodies in patients with gastrointestinal disorders","volume":"30","author":"Lutt","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.autrev.2020.102646_bb1840","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of anti-IgLON5-related tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.autrev.2020.102646_bb1845","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-170189","article-title":"Microglial and neuronal TDP-43 pathology in anti-IgLON5-related Tauopathy","volume":"59","author":"Cagnin","year":"2017","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.autrev.2020.102646_bb1850","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2020.102646_bb1855","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1212\/WNL.0000000000005859","article-title":"IgLON5: a case with predominant cerebellar tau deposits and leptomeningeal inflammation","volume":"91","author":"Schoberl","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2020.102646_bb1860","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng1297-393","article-title":"Positional cloning of the APECED gene","volume":"17","author":"Nagamine","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2020.102646_bb1865","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cell.2016.06.024","article-title":"AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies","volume":"166","author":"Meyer","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2020.102646_bb1870","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines","volume":"207","author":"Kisand","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102646_bb1875","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/iid3.109","article-title":"IL-6-specific autoantibodies among APECED and thymoma patients","volume":"4","author":"Karner","year":"2016","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.autrev.2020.102646_bb1880","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/eji.201747209","article-title":"IL-22 neutralizing autoantibodies impair fungal clearance in murine oropharyngeal candidiasis model","volume":"48","author":"Bichele","year":"2018","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2020.102646_bb1885","doi-asserted-by":"crossref","first-page":"13009","DOI":"10.1073\/pnas.0806874105","article-title":"B cells are required for Aire-deficient mice to develop multi-organ autoinflammation: a therapeutic approach for APECED patients","volume":"105","author":"Gavanescu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102646_bb1890","doi-asserted-by":"crossref","first-page":"874","DOI":"10.4049\/jimmunol.1701318","article-title":"Breakdown of immune tolerance in AIRE-deficient rats induces a severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy-like autoimmune disease","volume":"201","author":"Ossart","year":"2018","journal-title":"J Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220302172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220302172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:21:53Z","timestamp":1761600113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220302172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":378,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1568997220302172"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102646","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on IgG4-mediated autoimmune diseases: New insights and new family members","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102646"}}